Literature DB >> 22405162

Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy.

Gema de la Poza1, Antonio López-Sanroman, Carlos Taxonera, Ignacio Marín-Jimenez, Javier P Gisbert, Fernando Bermejo, Verónica Opio, Alfonso Muriel.   

Abstract

BACKGROUND: Genital fistulas (GF) can arise in the course of Crohn's disease (CD), are difficult to manage and determine a significant alteration of the quality of life. AIMS: To review the joint experience of the Inflammatory Bowel Disease Units in six University Hospitals in the management of GF in Crohn's disease on female patients.
RESULTS: A total of 47 patients with GF were identified, affecting 3.8% of women with CD treated in our centers. A 47.5% of patients were smokers. The median of time from the diagnosis of CD reached 102 months. According to anatomical type, GF were classified as rectovaginal (74.5%), anovaginal/anovulvar (21.3%) and enterovaginal (4.3%). Main symptoms were vaginal discharge of fecal material (55.3%), vaginal passage of gas (40.4%), or both. Fistulas were treated with antibiotics in 59.6% of patients, without any lasting success. Thiopurines were used in 80.9% of cases, with 13.2% of complete and 23.7% of partial responses. Anti TNF-alpha therapy was applied in 63.8%, with a 16.7% of complete and a 30% of partial responses (all responding patients received infliximab). Surgery was indicated in 38.3% of patients, with a 22% of complete responses after a first operation and 38.8% after reintervention. In all, definitive closure after one or more of these therapies was achieved in only 31.9% of cases.
CONCLUSION: Genital fistulas are a significant problem in female Crohn's disease patients. Therapy is not well defined and only partially effective (one in three cases). Surgical therapy stands out as the most effective treatment. Copyright Â
© 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22405162     DOI: 10.1016/j.crohns.2011.08.015

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  10 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

2.  Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial.

Authors:  Mariano García-Arranz; Maria Dolores Herreros; Carolina González-Gómez; Paloma de la Quintana; Héctor Guadalajara; Tihomir Georgiev-Hristov; Jacobo Trébol; Damián Garcia-Olmo
Journal:  Stem Cells Transl Med       Date:  2016-07-13       Impact factor: 6.940

3.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

4.  Martius' flap for recurrent perineal and rectovaginal fistulae in a patient with Crohn's disease, endometriosis and a mullerian anomaly.

Authors:  Gaetano Gallo; Alberto Realis Luc; Giuseppe Clerico; Mario Trompetto
Journal:  BMC Surg       Date:  2017-11-21       Impact factor: 2.102

Review 5.  Second Korean guidelines for the management of Crohn's disease.

Authors:  Jae Jun Park; Suk-Kyun Yang; Byong Duk Ye; Jong Wook Kim; Dong Il Park; Hyuk Yoon; Jong Pil Im; Kang Moon Lee; Sang Nam Yoon; Heeyoung Lee
Journal:  Intest Res       Date:  2017-01-31

6.  Identifying perianal fistula complications in pediatric patients with Crohn's disease using administrative claims.

Authors:  Jeremy Adler; Hannah K Jary; Sally J Eder; Shiming Dong; Emily Brandt; Jessica K Haraga; Kevin J Dombkowski
Journal:  PLoS One       Date:  2019-08-14       Impact factor: 3.240

7.  Long-term outcomes of anti-tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease.

Authors:  Sudheer K Vuyyuru; Devendra Desai; Saurabh Kedia; Pavan Dhoble; Pabitra Sahu; Bhaskar Kante; Samagra Agarwal; Sawan Bopanna; Rajan Dhingra; Pratap Mouli Venigalla; Raju Sharma; Siddhartha Datta Gupta; Govind Makharia; Peush Sahni; Vineet Ahuja
Journal:  JGH Open       Date:  2021-03-26

8.  Systemic lupus erythematosus complicated by Crohn's disease with rectovaginal fistula.

Authors:  Heng Yeh; Ren-Chin Wu; Wen-Sy Tsai; Chia-Jung Kuo; Ming-Yao Su; Cheng-Tang Chiu; Puo-Hsien Le
Journal:  BMC Gastroenterol       Date:  2021-05-08       Impact factor: 3.067

9.  Surgical mistake causing an high recto-vaginal fistula. A case report with combined surgical and endoscopic approach: therapeutic considerations.

Authors:  Michele Danzi; Fabozzi Massimiliano; Reggio Stefano; Pannullo Mario; Amato Bruno; Grimaldi Luciano
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

10.  Hyperbaric oxygen therapy for the treatment of rectovaginal fistulas in patients with Crohn's disease: results of the HOT-REVA pilot study.

Authors:  C A Lansdorp; C J Buskens; K B Gecse; G R A M D'Haens; R A van Hulst
Journal:  BJS Open       Date:  2021-05-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.